797 related articles for article (PubMed ID: 10986126)
21. Determination of the structure of oxidised Desulfovibrio africanus ferredoxin I by 1H NMR spectroscopy and comparison of its solution structure with its crystal structure.
Davy SL; Osborne MJ; Moore GR
J Mol Biol; 1998 Apr; 277(3):683-706. PubMed ID: 9533888
[TBL] [Abstract][Full Text] [Related]
22. Solution structure of murine macrophage inflammatory protein-2.
Shao W; Jerva LF; West J; Lolis E; Schweitzer BI
Biochemistry; 1998 Jun; 37(23):8303-13. PubMed ID: 9622482
[TBL] [Abstract][Full Text] [Related]
23. Nuclear magnetic resonance solution structure of truncated human GRObeta [5-73] and its structural comparison with CXC chemokine family members GROalpha and IL-8.
Qian YQ; Johanson KO; McDevitt P
J Mol Biol; 1999 Dec; 294(5):1065-72. PubMed ID: 10600366
[TBL] [Abstract][Full Text] [Related]
24. Amber force field implementation, molecular modelling study, synthesis and MMP-1/MMP-2 inhibition profile of (R)- and (S)-N-hydroxy-2-(N-isopropoxybiphenyl-4-ylsulfonamido)-3-methylbutanamides.
Tuccinardi T; Martinelli A; Nuti E; Carelli P; Balzano F; Uccello-Barretta G; Murphy G; Rossello A
Bioorg Med Chem; 2006 Jun; 14(12):4260-76. PubMed ID: 16483784
[TBL] [Abstract][Full Text] [Related]
25. Crystal structure of an elastase-specific inhibitor elafin complexed with porcine pancreatic elastase determined at 1.9 A resolution.
Tsunemi M; Matsuura Y; Sakakibara S; Katsube Y
Biochemistry; 1996 Sep; 35(36):11570-6. PubMed ID: 8794736
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the utility of NMR structures determined from minimal NOE-based restraints for structure-based drug design, using MMP-1 as an example.
Huang X; Moy F; Powers R
Biochemistry; 2000 Nov; 39(44):13365-75. PubMed ID: 11063573
[TBL] [Abstract][Full Text] [Related]
27. Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.
Matter H; Schwab W; Barbier D; Billen G; Haase B; Neises B; Schudok M; Thorwart W; Schreuder H; Brachvogel V; Lönze P; Weithmann KU
J Med Chem; 1999 Jun; 42(11):1908-20. PubMed ID: 10354399
[TBL] [Abstract][Full Text] [Related]
28. The solution structure of ribosomal protein L36 from Thermus thermophilus reveals a zinc-ribbon-like fold.
Härd T; Rak A; Allard P; Kloo L; Garber M
J Mol Biol; 2000 Feb; 296(1):169-80. PubMed ID: 10656825
[TBL] [Abstract][Full Text] [Related]
29. X-ray structure of human stromelysin catalytic domain complexed with nonpeptide inhibitors: implications for inhibitor selectivity.
Pavlovsky AG; Williams MG; Ye QZ; Ortwine DF; Purchase CF; White AD; Dhanaraj V; Roth BD; Johnson LL; Hupe D; Humblet C; Blundell TL
Protein Sci; 1999 Jul; 8(7):1455-62. PubMed ID: 10422833
[TBL] [Abstract][Full Text] [Related]
30. Assignments, secondary structure and dynamics of the inhibitor-free catalytic fragment of human fibroblast collagenase.
Moy FJ; Pisano MR; Chanda PK; Urbano C; Killar LM; Sung ML; Powers R
J Biomol NMR; 1997 Jul; 10(1):9-19. PubMed ID: 9335112
[TBL] [Abstract][Full Text] [Related]
31. 1.56 A structure of mature truncated human fibroblast collagenase.
Spurlino JC; Smallwood AM; Carlton DD; Banks TM; Vavra KJ; Johnson JS; Cook ER; Falvo J; Wahl RC; Pulvino TA
Proteins; 1994 Jun; 19(2):98-109. PubMed ID: 8090713
[TBL] [Abstract][Full Text] [Related]
32. [A turning point in the knowledge of the structure-function-activity relations of elastin].
Alix AJ
J Soc Biol; 2001; 195(2):181-93. PubMed ID: 11727705
[TBL] [Abstract][Full Text] [Related]
33. Extra binding region induced by non-zinc chelating inhibitors into the S1' subsite of matrix metalloproteinase 8 (MMP-8).
Pochetti G; Montanari R; Gege C; Chevrier C; Taveras AG; Mazza F
J Med Chem; 2009 Feb; 52(4):1040-9. PubMed ID: 19173605
[TBL] [Abstract][Full Text] [Related]
34. NMR structure of the DNA-binding domain of the cell cycle protein Mbp1 from Saccharomyces cerevisiae.
Nair M; McIntosh PB; Frenkiel TA; Kelly G; Taylor IA; Smerdon SJ; Lane AN
Biochemistry; 2003 Feb; 42(5):1266-73. PubMed ID: 12564929
[TBL] [Abstract][Full Text] [Related]
35. Crystal structure of human MMP9 in complex with a reverse hydroxamate inhibitor.
Rowsell S; Hawtin P; Minshull CA; Jepson H; Brockbank SM; Barratt DG; Slater AM; McPheat WL; Waterson D; Henney AM; Pauptit RA
J Mol Biol; 2002 May; 319(1):173-81. PubMed ID: 12051944
[TBL] [Abstract][Full Text] [Related]
36. The dimerization domain of HNF-1alpha: structure and plasticity of an intertwined four-helix bundle with application to diabetes mellitus.
Narayana N; Hua Q; Weiss MA
J Mol Biol; 2001 Jul; 310(3):635-58. PubMed ID: 11439029
[TBL] [Abstract][Full Text] [Related]
37. The origin of differences in the physical properties of the equilibrium forms of cytochrome b5 revealed through high-resolution NMR structures and backbone dynamic analyses.
Dangi B; Sarma S; Yan C; Banville DL; Guiles RD
Biochemistry; 1998 Jun; 37(23):8289-302. PubMed ID: 9622481
[TBL] [Abstract][Full Text] [Related]
38. Three-dimensional structure of the immunophilin-like domain of FKBP59 in solution.
Craescu CT; Rouvière N; Popescu A; Cerpolini E; Lebeau MC; Baulieu EE; Mispelter J
Biochemistry; 1996 Aug; 35(34):11045-52. PubMed ID: 8780506
[TBL] [Abstract][Full Text] [Related]
39. The solution structure of melanoma growth stimulating activity.
Fairbrother WJ; Reilly D; Colby TJ; Hesselgesser J; Horuk R
J Mol Biol; 1994 Sep; 242(3):252-70. PubMed ID: 8089846
[TBL] [Abstract][Full Text] [Related]
40. Metal-dependent conformational changes in a recombinant vWF-A domain from human factor B: a solution study by circular dichroism, fourier transform infrared and (1)H NMR spectroscopy.
Hinshelwood J; Perkins SJ
J Mol Biol; 2000 Apr; 298(1):135-47. PubMed ID: 10756110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
